I am writing with regards to the Opinion piece titled, “Our Drug Supply Is Sick. How Can We Fix It?” (Sept. 18, 2021). As the writer clearly highlights, the U.S. generic pharmaceutical industry is facing a crisis. Our company, Nexus Pharmaceuticals, Inc., is leading...
LINCOLNSHIRE, Ill.–(BUSINESS WIRE)–Nexus Pharmaceuticals, Inc., a U.S.-based healthcare company and domestic pharmaceutical manufacturer, has received a patent covering applications of EMERPHED® Ready-To-Use Ephedrine Sulfate Injection, the first...
PLEASANT PRAIRIE, Wis.–(BUSINESS WIRE)–On Friday, July 16, 2021, Nexus Pharmaceuticals, Inc., a U.S.-based healthcare company and domestic pharmaceutical manufacturer, celebrated the opening of Project Tomorrow—the company’s new, state-of-the-art...
Milwaukee, June 21, 2021 – The Medical College of Wisconsin (MCW) School of Pharmacy partnered with Nexus Pharmaceuticals, Inc. for a pharmaceutical clinical-use study to compare the use of EMERPHED™, a ready-to-use (RTU) ephedrine sulfate product, to the...
KENOSHA, Wis. — Parkside Athletics and Nexus Pharmaceuticals are thrilled to announce a multi-year partnership in support of RangerVision 2020, Director of Athletics Andrew Gavin announced today. The partnership is highlighted by the creation of The Nexus...
